Fel d 1‐derived T cell peptide therapy induces recruitment of CD4⁺CD25⁺; CD4⁺ interferon‐γ⁺ T helper type 1 cells to sites of allergen‐induced late‐phase skin reactions in cat‐allergic subjects

Abstract

Treatment with allergen-derived T cell peptides results in allergen-dependent recruitment to the skin of Th1, rather than T regulatory cells, to cutaneous late-phase reaction sites.